Vahanian & Associates Financial Planning Inc. Pfizer Inc Transaction History

Vahanian & Associates Financial Planning Inc.

  • $24.5 Million
  • Q4 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023
SELL
$39.39 - $51.28 $99,893 - $130,046
-2,536 Reduced 24.6%
7,774 $317,000
Q4 2022

Jan 31, 2023
BUY
$41.75 - $54.5 $20,875 - $27,250
500 Added 5.1%
10,310 $528,000
Q3 2022

Nov 02, 2022
BUY
$43.76 - $53.42 $429,285 - $524,050
9,810 New
9,810 $429,000
Q1 2022

Apr 27, 2022
SELL
$45.75 - $56.69 $428,448 - $530,901
-9,365 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$41.32 - $61.25 $386,961 - $573,606
9,365 New
9,365 $553,000

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vahanian & Associates Financial Planning Inc. Portfolio

Follow Vahanian & Associates Financial Planning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vahanian & Associates Financial Planning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vahanian & Associates Financial Planning Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email